Health TrialsbyHealthPanel

The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

ConditionCorneal Diseases
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-80
SponsorSohag University

About this trial

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients with cataract

more than 40 years

no glaucoma

no retinal abnormalities

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • phacoemulsification

    Other intervention

    one group with BSS at room temperature and the other group with cold BSS

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: group 1Other 1 intervention
Group B: group 2Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

endothelial cell count

Time frame
3 months

Secondary outcomes

1

incidence of anterior segment inflammation

incidence of anterior segment inflammation including conjunctival hypremia or corneal edema

Time frame
3 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: